Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristin Williamson

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Vision|January 8, 2010
Experience-dependent changes in the topography of visual crowdingKristin Williamson, Miranda Scolari, Sukeun Jeong, et al.
American Heart Journal|April 2, 2025
Effects of angiotensin-neprilysin inhibition in women vs men: Insights from PARAGLIDE-HFPaula Rambarat, Tyler Erickson, Derek Cyr, et al.
Journal of Cardiac Failure|February 16, 2023
Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure EventRobert J Mentz, Jonathan H Ward, Adrian F Hernandez, et al.
Journal of the American Heart Association|February 19, 2025
In-Hospital or Out-of-Hospital Initiation of Sacubitril/Valsartan Versus Valsartan in Patients With Mildly Reduced or Preserved Ejection Fraction After A Worsening Heart Failure Event: The PARAGLIDE-HF TrialNina Nouhravesh, Derek Cyr, Adrian F Hernandez, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Vision|January 8, 2010
Experience-dependent changes in the topography of visual crowdingKristin Williamson, Miranda Scolari, Sukeun Jeong, et al.
American Heart Journal|April 2, 2025
Effects of angiotensin-neprilysin inhibition in women vs men: Insights from PARAGLIDE-HFPaula Rambarat, Tyler Erickson, Derek Cyr, et al.
Journal of Cardiac Failure|February 16, 2023
Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure EventRobert J Mentz, Jonathan H Ward, Adrian F Hernandez, et al.
Journal of the American Heart Association|February 19, 2025
In-Hospital or Out-of-Hospital Initiation of Sacubitril/Valsartan Versus Valsartan in Patients With Mildly Reduced or Preserved Ejection Fraction After A Worsening Heart Failure Event: The PARAGLIDE-HF TrialNina Nouhravesh, Derek Cyr, Adrian F Hernandez, et al.
Pageof 1